Incyte Corp (INCY)

Incyte (INCY) Stock Price & Analysis


INCY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$65.07 - $86.29
Previous Close$70.23
Average Volume (3M)1.66M
Market Cap
Enterprise Value$12.46B
Total Cash (Recent Filing)$3.24B
Total Debt (Recent Filing)$41.46M
Price to Earnings (P/E)46.1
May 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.52
Shares Outstanding222,965,018
10 Day Avg. Volume2,065,224
30 Day Avg. Volume1,663,717
Standard Deviation0.09
Financial Highlights & Ratios
Price to Book (P/B)4.31
Price to Sales (P/S)5.19
Price to Cash Flow (P/CF)18.20
P/FCF Ratio19.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.67
Enterprise Value/Gross Profit3.91
Enterprise Value/Ebitda20.78
Price Target Upside25.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Incyte Corp’s price range in the past 12 months?
Incyte Corp lowest stock price was $65.07 and its highest was $86.29 in the past 12 months.
    What is Incyte Corp’s market cap?
    Currently, no data Available
    When is Incyte Corp’s upcoming earnings report date?
    Incyte Corp’s upcoming earnings report date is May 02, 2023 which is in 38 days.
      How were Incyte Corp’s earnings last quarter?
      Incyte Corp released its earnings results on Feb 07, 2023. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.3 by -$0.17.
        Is Incyte Corp overvalued?
        According to Wall Street analysts Incyte Corp’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Incyte Corp pay dividends?
          Incyte Corp does not currently pay dividends.
          What is Incyte Corp’s EPS estimate?
          Incyte Corp’s EPS estimate is $0.54.
            How many shares outstanding does Incyte Corp have?
            Incyte Corp has 222,965,010 shares outstanding.
              What happened to Incyte Corp’s price movement after its last earnings report?
              Incyte Corp reported an EPS of $0.13 in its last earnings report, missing expectations of $0.3. Following the earnings report the stock price went down -4.03%.
                Which hedge fund is a major shareholder of Incyte Corp?
                Among the largest hedge funds holding Incyte Corp’s share is Baker Bros Advisors LP. It holds Incyte Corp’s shares valued at 3B.


                  Incyte Stock Smart Score

                  The Incyte stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Incyte Corp

                  Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.


                  Top 5 ETFs holding INCY

                  Market Value
                  Smart Score
                  VanEck Biotech ETF
                  Mul Ly W Ut TR Shs -C-USD- Capitalisation
                  Democratic Large Cap Core ETF
                  First Trust Growth Strength ETF
                  Up to five ETFs with an Outperform Smart Score that hold INCY. The ETFs are listed according to market value of INCY within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Alnylam Pharma
                  BioMarin Pharmaceutical

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis